The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

According to the latest study from BCC Research, "Cell and Gene Therapy Tools, and Reagents: Global Markets," is estimated to ...

Discover promising gene therapy results from Tenaya Therapeutics, Inc.'s TN-201 and TN-401 projects, potential impact on ...

Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...

Solid Biosciences (SLDB) stock was launched by Truist with a Buy rating based on positive catalysts and attractive valuation.

Bryan Johnson, who’s spending hundreds of millions of dollars on treatments designed to extend his life, is many things to ...

Researchers have successfully repaired damaged mouse hearts using a protein from zebrafish. They discovered that the protein Hmga1 plays a key role in heart regeneration in zebrafish. In mice, this ...

TUESDAY, Dec. 10, 2024 (HealthDay News) -- Failing hearts nearly returned to full function in laboratory pigs after they received an experimental gene therapy. New research shows the gene therapy didn ...

The global gene therapy market is expected to be worth USD 8.98 billion in 2024 and USD 57.13 billion by 2034, growing at a CAGR of 18.52% between the two years.Luton, Bedfordshire, United Kingdom, ...

The data suggests that Hmga1, a key protein for regenerating heart cells, could be a target for gene therapies that prevent cardiac failure.